Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron Transdermal System vs Oral Granisetron for CINV
NCT00273468Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Jan 2006
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of granisetron in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Kyowa Kirin. Primary endpoint: Percentage of patients achieving Complete Control of CINV. Started Jan 2006; status: completed.
02
Drugs
granisetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00273468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273468.